Burnet Bloodwort
Sanguisorba officinalis
Sanguisorba officinalis, commonly known as bloody dock or common burnet, originates from traditional medicine practices in Europe and Asia. It has been traditionally used for various purposes such as treating burns, wounds, and skin conditions, though specific uses vary across different cultures. Scientific evidence suggests that S. officinalis contains bioactive compounds with potential benefits, including inhibiting melanogenesis and promoting megakaryocyte differentiation through ERα-dependent signaling pathways. Additionally, extracts from this plant have shown promise in alleviating chemotherapy-induced neutropenia by enhancing neutrophil differentiation and functional recovery. Regarding safety, no significant adverse effects or major issues have been reported to date. There is currently no evidence of drug interactions with Sanguisorba officinalis, though further research is needed to fully understand its potential applications and mechanisms of action.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study identified twelve new sesquiterpenoids from Sanguisorba officinalis roots, some of which showed significant inhibitory activity against melanogenesis.
- Sanguisorba officinalis L. monomer epigallocatechin promotes megakaryocyte differentiation via ERα-dependent SRC/PI3K/AKT signaling in vitro and in vivo without toxicity.
- Ziyuglycoside II from Sanguisorba officinalis alleviates chemotherapy-induced neutropenia by promoting neutrophil differentiation and functional recovery through SPI1 and C/EBPϵ regulation.
- Kytococcus, particularly K. schroeteri and S. hominis, are associated with foot malodor, while extracts from Sanguisorba officinalis and Eucalyptus globulus can inhibit isovaleric acid production.
Frequently asked questions
What is Burnet Bloodwort?
Burnet Bloodwort (Sanguisorba officinalis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Burnet Bloodwort?
4 sourced findings are recorded for Burnet Bloodwort; the strongest carries evidence grade D. For example: The study identified twelve new sesquiterpenoids from Sanguisorba officinalis roots, some of which showed significant inhibitory activity against melanogenesis.
How strong is the evidence for Burnet Bloodwort?
The strongest finding for Burnet Bloodwort carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Burnet Bloodwort safe? What are the side effects?
No major safety issues are recorded for Burnet Bloodwort in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Burnet Bloodwort interact with medications?
No drug interactions are recorded for Burnet Bloodwort in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Burnet Bloodwort?
Burnet Bloodwort is also known as: Кровохлёбка лекарственная, Grande pimprenelle.
Is Burnet Bloodwort a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Ziyuglycoside II ameliorates chemotherapy-induced neutropenia by promoting neutrophil differentiation and functional recovery via SPI1 and C/EBPϵ transcriptional regulation. literature abstract metadata
- T2 Epigallocatechin promotes megakaryocyte differentiation via ERα-dependent SRC/PI3K/AKT signaling for thrombocytopenia treatment. literature abstract metadata
- T2 New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity. literature abstract metadata
- T2 Kytococcal and staphylococcal strains isolated from Japanese subjects with foot malodor and their control. literature abstract metadata